Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery

NCT03756233 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT03756233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03756233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 26, 2018
Completion date
July 3, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative